Phase II Study of Vandetanib in Individuals With Kidney Cancer

NCT00566995 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Renal Cancer
Von Hippel Lindau

Interventions

DRUG: ZACTIMA (Vandetanib) (ZD6474)

Sponsor

National Cancer Institute (NCI)